Behzad Khosrovi - Net Worth and Insider Trading

Behzad Khosrovi Net Worth

The estimated net worth of Behzad Khosrovi is at least $3 dollars as of 2024-11-13. Behzad Khosrovi is the VP Research and Development of NovaBay Pharmaceuticals Inc and owns about 4 shares of NovaBay Pharmaceuticals Inc (NBY) stock worth over $3. Details can be seen in Behzad Khosrovi's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Behzad Khosrovi has not made any transactions after 2011-05-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Behzad Khosrovi

To

Behzad Khosrovi Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Behzad Khosrovi owns 1 companies in total, including NovaBay Pharmaceuticals Inc (NBY) .

Click here to see the complete history of Behzad Khosrovi’s form 4 insider trades.

Insider Ownership Summary of Behzad Khosrovi

Ticker Comapny Transaction Date Type of Owner
NBY NovaBay Pharmaceuticals Inc 2011-05-27 VP Research and Development

Behzad Khosrovi Latest Holdings Summary

Behzad Khosrovi currently owns a total of 1 stock. Behzad Khosrovi owns 4 shares of NovaBay Pharmaceuticals Inc (NBY) as of May 27, 2011, with a value of $3.

Latest Holdings of Behzad Khosrovi

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NBY NovaBay Pharmaceuticals Inc 2011-05-27 4 0.78 3

Holding Weightings of Behzad Khosrovi


Behzad Khosrovi Form 4 Trading Tracker

According to the SEC Form 4 filings, Behzad Khosrovi has made a total of 0 transactions in NovaBay Pharmaceuticals Inc (NBY) over the past 5 years. The most-recent trade in NovaBay Pharmaceuticals Inc is the acquisition of 0 shares on May 27, 2011, which cost Behzad Khosrovi around $1,640.

Insider Trading History of Behzad Khosrovi

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Behzad Khosrovi Trading Performance

GuruFocus tracks the stock performance after each of Behzad Khosrovi's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Behzad Khosrovi is -45.91%. GuruFocus also compares Behzad Khosrovi's trading performance to market benchmark return within the same time period. The performance of stocks bought by Behzad Khosrovi within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Behzad Khosrovi's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Behzad Khosrovi

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -30.19 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -26.36 LIMIT LIMIT LIMIT LIMIT LIMIT

Behzad Khosrovi Ownership Network

Ownership Network List of Behzad Khosrovi

No Data

Ownership Network Relation of Behzad Khosrovi

Insider Network Chart

Behzad Khosrovi Owned Company Details

What does NovaBay Pharmaceuticals Inc do?

Who are the key executives at NovaBay Pharmaceuticals Inc?

Behzad Khosrovi is the VP Research and Development of NovaBay Pharmaceuticals Inc. Other key executives at NovaBay Pharmaceuticals Inc include Interim CFO Tommy Law , President & DERMAdoctor & LLC Jeffrey Kunin , and Chief Product Officer Audrey Kunin .

NovaBay Pharmaceuticals Inc (NBY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of NovaBay Pharmaceuticals Inc (NBY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NovaBay Pharmaceuticals Inc (NBY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NovaBay Pharmaceuticals Inc (NBY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

NovaBay Pharmaceuticals Inc Insider Transactions

No Available Data

Behzad Khosrovi Mailing Address

Above is the net worth, insider trading, and ownership report for Behzad Khosrovi. You might contact Behzad Khosrovi via mailing address: C/o Novabay Pharmaceuticals, Inc., 5980 Horton Street, Suite 550, Emeryville Ca 94608.